IPO registrations (S-1, F-1) · Registrants
UNIGENE LABORATORIES INC
- SEC CIK
- 352747 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2001-01-19, last 2012-10-19; 10 initial registrations, 7 amendments
- Outcome
- Declared effective 2006-07-12; withdrawal requested 2001-05-01
- Industry (SIC)
- Medicinal Chemicals & Botanical Products 2833
- Incorporated in
- DE
- Business address
- 81 FULTON STREET, Boonton, NJ 07005
- EIN
- 22-2328609
- EDGAR entity type
- operating
- Insiders and CEO pay
- UNIGENE LABORATORIES INC on the corporate pages
Offering terms
- Shares offered
- 161,739,676
- Listing
- OTCQB under the symbol UGNE
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: UNIGENE LABORATORIES, INC. C/O GREENBAUM, ROWE, SMITH & DAVIS EXACT (EIN (EXACT))
- Federal award recipient: UNIGENE LABORATORIES, INC. Fuzzy (name and state)
- SEC filer: UNIGENE LABORATORIES INC EXACT (CIK (EXACT))
Filings 26
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2001-01-19 | S-1 | S-1 (registration) | UNIGENE LABORATORIES INC | 0000914317-01-000045 ↗ |
| 2001-02-08 | S-1/A | S-1/A (amendment) | UNIGENE LABORATORIES INC | 0000914317-01-000073 ↗ |
| 2001-04-10 | S-1/A | S-1/A (amendment) | UNIGENE LABORATORIES INC | 0000914317-01-000293 ↗ |
| 2001-04-27 | S-1 | S-1 (registration) | UNIGENE LABORATORIES INC | 0000914317-01-500031 ↗ |
| 2001-05-01 | RW | RW (withdrawal request) | UNIGENE LABORATORIES INC | 0000914317-01-500049 ↗ |
| 2001-05-01 | RW | RW (withdrawal request) | UNIGENE LABORATORIES INC | 0000914317-01-500050 ↗ |
| 2001-05-10 | S-1 | S-1 (registration) | UNIGENE LABORATORIES INC | 0000914317-01-500067 ↗ |
| 2001-12-26 | S-1 | S-1 (registration) | UNIGENE LABORATORIES INC | 0000914317-01-500546 ↗ |
| 2002-01-10 | S-1 | S-1 (registration) | UNIGENE LABORATORIES INC | 0000914317-02-000014 ↗ |
| 2002-01-25 | S-1/A | S-1/A (amendment) | UNIGENE LABORATORIES INC | 0000928385-02-000196 ↗ |
| 2002-02-11 | S-1/A | S-1/A (amendment) | UNIGENE LABORATORIES INC | 0000930661-02-000364 ↗ |
| 2002-04-26 | S-1 | S-1 (registration) | UNIGENE LABORATORIES INC | 0001021408-02-005848 ↗ |
| 2002-05-07 | S-1/A | S-1/A (amendment) | UNIGENE LABORATORIES INC | 0001021408-02-006204 ↗ |
| 2003-10-10 | S-1 | S-1 (registration) | UNIGENE LABORATORIES INC | 0001193125-03-060482 ↗ |
| 2003-11-07 | S-1/A | S-1/A (amendment) | UNIGENE LABORATORIES INC | 0001193125-03-075344 ↗ |
| 2006-04-14 | S-1 | S-1 (registration) | UNIGENE LABORATORIES INC | 0001193125-06-080431 ↗ |
| 2006-07-12 | EFFECT | EFFECT (declared effective) | UNIGENE LABORATORIES INC | 9999999995-06-000703 ↗ |
| 2006-08-22 | EFFECT | EFFECT (declared effective) | UNIGENE LABORATORIES INC | 9999999995-06-001305 ↗ |
| 2006-09-13 | EFFECT | EFFECT (declared effective) | UNIGENE LABORATORIES INC | 9999999995-06-001504 ↗ |
| 2010-01-08 | EFFECT | EFFECT (declared effective) | UNIGENE LABORATORIES INC | 9999999995-10-000164 ↗ |
| 2010-03-29 | RW | RW (withdrawal request) | UNIGENE LABORATORIES INC | 0001437749-10-000819 ↗ |
| 2010-05-14 | S-1 | S-1 (registration) | UNIGENE LABORATORIES INC | 0001437749-10-001510 ↗ |
| 2010-07-06 | S-1/A | S-1/A (amendment) | UNIGENE LABORATORIES INC | 0001437749-10-002111 ↗ |
| 2010-07-13 | EFFECT | EFFECT (declared effective) | UNIGENE LABORATORIES INC | 9999999995-10-002118 ↗ |
| 2011-04-21 | EFFECT | EFFECT (declared effective) | UNIGENE LABORATORIES INC | 9999999995-11-001111 ↗ |
| 2012-10-19 | S-1 | S-1 (registration) | UNIGENE LABORATORIES INC | 0001437749-12-010420 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2012-10-19 | S-1 | registration statement | 161,739,676 | - | OTCQB UGNE | 0 | primary document; shares headline | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| GILLIGAN JAMES P | Officer | Vice Pres. of Product Devel. | 9 | 2006–2010 | |
| Mehta Nozer | Officer | Chief Scientific Officer; Vice Pres. Biological R&D; VP, Biological R&D; VP, R&D | 13 | 2006–2012 | |
| MORRA BRUCE S | Director | 9 | 2006–2010 | ||
| SLUSSER PETER | Director | 13 | 2006–2010 | ||
| Shields Paul | Officer | Vice Pres. Mfg.; Vice Pres. Mfg. Operations | 16 | 2006–2012 | |
| Steinhauer William Jacob | Officer; Other | Vice President of Finance | 11 | 2006–2012 | |
| AUGUST JOSEPH T | Director | 9 | 2006–2010 | ||
| BLOOM ALLEN | Director | 16 | 2006–2011 | ||
| HENDRICKSON ROBERT F | Director | 6 | 2006–2009 | ||
| MILLER MARVIN | Director | 14 | 2006–2011 | ||
| LEVY JAY | Director,Officer | Chairman of the Bd.; Treasurer | 6 | 2007–2010 | |
| LEVY RONALD S | Director,Officer | Executive Vice President | 8 | 2007–2010 | |
| LEVY WARREN P | Director,Officer | President; President & CEO | 9 | 2007–2010 | |
| Bourne Richard J | Officer | VP Global Regulatory Affairs | 2 | 2007–2009 | |
| ZVI EIREF | Director | 13 | 2009–2012 | ||
| Levy Richard N | Director; Director,TenPercentOwner | 20 | 2010–2013 | ||
| Palmer Ashleigh | Director,Officer | Chief Executive Officer; President & CEO | 8 | 2010–2012 | |
| Tune Joel A. | Director | 11 | 2010–2013 | ||
| Mayes, Gregory T. | Director,Officer; Officer | Chief Business Officer; President and General Counsel; VP, Corp Development and GC; VP, Corporate Affairs | 7 | 2010–2012 | |
| Tavakkol Roxanne | Officer | Vice President; VP, Global Regulatory Affairs; VP, GRA & QA | 6 | 2010–2012 | |
| Martin John Alexander | Officer | VP of Business Development | 1 | 2010 | |
| Thomas Jenene D. | Officer | VP of Investor Relations | 6 | 2010–2012 | |
| Jacob Capital, L.L.C. | Director,TenPercentOwner; TenPercentOwner | 11 | 2011–2013 | ||
| Victory Park Capital Advisors, LLC | Director,TenPercentOwner; TenPercentOwner | 10 | 2011–2013 | ||
| Victory Park GP II, LLC | Director,TenPercentOwner; TenPercentOwner | 9 | 2011–2013 | ||
| Victory Park Master Fund, Ltd. | Director,TenPercentOwner; TenPercentOwner | 4 | 2011–2012 | ||
| VPC Fund II, L.P. | Director,TenPercentOwner; TenPercentOwner | 9 | 2011–2013 | ||
| VPC Intermediate Fund II (Cayman), L.P. | DirectorOther; Director,TenPercentOwner | 6 | 2011–2013 | ||
| Odlaug Theron Edwin | Director | 8 | 2011–2013 | ||
| SABATINO THOMAS J JR | Director | 7 | 2011–2013 | ||
| Moskowitz David | Officer | CFO | 1 | 2012 | |
| WYSZOMIERSKI JACK L | Director | 5 | 2012–2013 | ||
| Zietsman Brian | Officer | Chief Financial Officer; Executive Director, Finance | 3 | 2012 | |
| Victory Park Credit Opportunities Intermediate Fund, L.P. | Director,TenPercentOwner | 6 | 2012–2013 | ||
| VICTORY PARK CREDIT OPPORTUNITIES LP | Director,TenPercentOwner | 6 | 2012–2013 | ||
| Victory Park GP, LLC | Director,TenPercentOwner | 6 | 2012–2013 | ||
| RNL VPC, LLC | Director,TenPercentOwner | 5 | 2013 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Federal award recipient | UNIGENE LABORATORIES, INC. | NJ | Federal spending (USAspending) | name and state |
| Patent assignee | Unigene Laboratories Inc. | NJ | Patents (USPTO) | name and state |
| SEC filer | UNIGENE LABORATORIES INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Unigene Laboratories, Inc. | NJ | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | UNIGENE LABORATORIES, INC. C/O GREENBAUM, ROWE, SMITH & DAVIS | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Medicinal Chemicals & Botanical Products, NJ first:
- VITAQUEST INTERNATIONAL INC NJ
- TRIARCO INDUSTRIES INC NJ
- Ascend Wellness Holdings, Inc. NJ
- MEDICAL NUTRITION USA INC NJ
- First Person Ltd. A0
- CanaQuest Medical Corp. A6
- Canopy Growth Corp A6
- Devonian Health Group Inc. A8
- Adorbs Inc A9
- Glucose Health, Inc. AR
In other datasets, the same topic (Health) in NJ:
- Nonprofit: 1ST CEREBRAL PALSY OF NEW JERSEY INC (Nonprofits (IRS Form 990))
Interests: Medicinal Chemicals & Botanical Products · Health